|
Volumn 20, Issue 2, 2001, Pages 127-133
|
Oral oseltamivir treatment of influenza in children
|
Author keywords
Influenza; Neuraminidase inhibitor; Oseltamivir; Otitis media; Pediatrics
|
Indexed keywords
OSELTAMIVIR;
PLACEBO;
VIRUS ANTIBODY;
ANTIBODY RESPONSE;
ARTICLE;
CHILD;
CLINICAL TRIAL;
COMMON COLD;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HUMAN;
INFLUENZA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OTITIS MEDIA;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
VOMITING;
ACETAMIDES;
ADMINISTRATION, ORAL;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
COUGH;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INFANT;
INFLUENZA, HUMAN;
MALE;
OSELTAMIVIR;
SAFETY;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0035121720
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-200102000-00002 Document Type: Article |
Times cited : (644)
|
References (25)
|